Colorectal Cancer Screening Outreach
Part of paid clinical trials in New Haven, Connecticut.
- Sponsor
- Yale University
- Study ID
- NCT07345676
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Colo-rectal Cancer
Eligibility Criteria
- Sex
- ALL
- Age
- 45 Years - 75 Years
- Healthy Volunteers
- Not accepted
Interventions
- Bundled messaging intervention — BEHAVIORALA bundled intervention of text message, letter, and provider reminder. Text message content using behaviorally motivated messages will vary.
Study Details
This is a 4 arm pragmatic trial to test a multicomponent intervention designed to improve adherence to colorectal cancer screening.
Key Dates
- Start date
- Jun 30, 2026
- Status verified
- Apr 2026
- Primary completion
- Apr 30, 2027
- Completion
- Jul 31, 2027
Study Design
- Enrollment
- 2,000 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SCREENING
Arms
- No Intervention: Control-Usual CareParticipants will receive a simple text message reminder
- Experimental: Messaging Group AParticipants will receive a series of outreach messages including texts with two-way messaging capabilities, mailed letter, and a reminder to their clinician. Content of the text message arm will be varied so that patients receive one of three messages (A, B or C).
- Experimental: Messaging Group BParticipants will receive a series of outreach messages including texts with two-way messaging capabilities, mailed letter, and a reminder to their clinician. Content of the text message arm will be varied so that patients receive one of three messages (A, B or C).
- Experimental: Messaging Group CParticipants will receive a series of outreach messages including texts with two-way messaging capabilities, mailed letter, and a reminder to their clinician. Content of the text message arm will be varied so that patients receive one of three messages (A, B or C).
Primary Outcome Measure
Number of participants with scheduled or completed colorectal cancer screening. [ Time Frame: up to 3 months from randomization ]
Central Contacts
- Ilana Richman, MD203 737 1024
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Cornell Scott Hill Health | New Haven | Connecticut | 06519 | - |
Find similar trials in New Haven, CT
By research site
Related Studies
- Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer PatientsPHASE2 · Recruiting · Vyriad, Inc. · Phoenix, Arizona
- Shield Post-Approval Study ProtocolRecruiting · Guardant Health, Inc. · Chandler, Arizona
- Evaluation of SINGLE PORT (SP) Robotic Technology in Colorectal SurgeryRecruiting · University of California, Davis · Sacramento, California
- Eliminating Barriers to Colorectal Cancer Screening Using Rapid Cycle Testing: A Pilot StudyRecruiting · Massachusetts General Hospital · Boston, Massachusetts